Lensar (LNSR) Cash & Current Investments (2019 - 2026)
Lensar (LNSR) posted quarterly Cash & Current Investments of $11.1 million for Q1 2026, down 56.04% year-over-year from $25.2 million in Q1 2025, and down 37.85% quarter-over-quarter from $17.9 million in Q4 2025.
Lensar (LNSR) Cash & Current Investments (2019 - 2026) Analysis & Trends
Lensar (LNSR) has reported Cash & Current Investments for 8 consecutive years, with $11.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Current Investments fell 56.04% year-over-year to $11.1 million; the TTM figure through Mar 2026 stood at $11.1 million (down 56.04% YoY), while the FY2025 annual figure was $17.9 million, down 6.08% from the prior year.
- Cash & Current Investments eased to $11.1 million in Q1 2026 per LNSR's latest filing, from $17.9 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $29.0 million in Q1 2022 and bottomed at $11.1 million in Q1 2026.
- Historically, Cash & Current Investments has averaged $20.7 million across 5 years, with a median of $19.8 million in 2024.
- Annual changes were most pronounced in 2023 — Cash & Current Investments surged 63.99% — and 2026, when it tumbled 56.04%.
- Lensar's Cash & Current Investments stood at $14.7 million in 2022, then soared by 63.99% to $24.1 million in 2023, then slipped by 20.98% to $19.0 million in 2024, then decreased by 6.08% to $17.9 million in 2025, then plunged by 37.85% to $11.1 million in 2026.
- Business Quant data shows LNSR's Cash & Current Investments at $11.1 million in Q1 2026, $17.9 million in Q4 2025, and $22.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Lensar | 103.79 Mn | 90.22 Mn | 9.78 Mn | 13.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.57 Mn |
| Mar 31, 2026 | 11.10 Mn |
| Dec 31, 2025 | 17.86 Mn |
| Sep 30, 2025 | 21.99 Mn |
| Jun 30, 2025 | 20.31 Mn |
| Mar 31, 2025 | 25.25 Mn |
| Dec 31, 2024 | 19.02 Mn |
| Sep 30, 2024 | 18.08 Mn |
| Jun 30, 2024 | 18.41 Mn |
| Mar 31, 2024 | 19.26 Mn |
| Dec 31, 2023 | 24.06 Mn |
| Sep 30, 2023 | 24.92 Mn |
| Jun 30, 2023 | 25.47 Mn |
| Dec 31, 2022 | 14.67 Mn |
| Mar 31, 2022 | 28.98 Mn |
| Dec 31, 2021 | 31.64 Mn |
| Sep 30, 2021 | 32.34 Mn |
| Jun 30, 2021 | 34.55 Mn |
| Mar 31, 2021 | 35.87 Mn |
| Dec 31, 2020 | 40.60 Mn |